Oralanticoagulants take effect by inhibiting the pathway of coagulation.
抗凝药物通过对凝血途径加以抑制而起效。
2
For patients who are receiving a stable dose of oralanticoagulants, we suggest monitoring at an interval of no longer than every 4 weeks (Grade 2c).
对于使用稳定剂量口服抗凝剂的患者,我们推荐凝血功能监测时间间隔不超过4周(2 C)。
3
This study exemplifies that novel, specific oralanticoagulants may improve the current antithrombotic strategies while having a safer bleeding profile.